Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $150 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Tapan Maniar, Ph.D.

Tapan Maniar, Ph.D.

Vice President
Life Sciences
Boston

Experience

Dr. Maniar joined Bain Capital Life Sciences in September 2021. Prior to Bain Capital, he was at Genentech from 2017 to 2021, taking on the role of Genentech’s Head of Business Development for drug discovery technologies. During his tenure, Dr. Maniar led or oversaw 10+ transactions, expanding Genentech’s access to innovative modalities and technologies across therapeutic areas.  Previously, he was a senior Engagement Manager at McKinsey & Co, where he advised biopharmaceutical and healthcare organizations on a range of strategic topics across BD, R&D and commercial value and access.  
 


Education

Dr. Maniar earned his Ph.D. in Neuroscience at The Rockefeller University from Cori Bargmann’s lab, where he investigated the genetic and molecular basis of neuronal development.  He received his B.A. in Biology from Bard College.